A previous study indicated that proliferator-activated receptor γ (PPARγ) mediated adipogenesis and browning of fat protected liver damage in NAFLD and improved insulin sensitivity [36]. This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.